L-(-)-Ornithine

HCID 6262CAS 25104-12-5

Grundinformationen

Standard-SMILES
NCCC[C@H](N)C(=O)O
InChIKey
AHLPHDHHMVZTML-BYPYZUCNSA-N
Summenformel
C5H12N2O2
Durchschnittliche Molmasse
132,16 g/mol
Monoisotopische Masse
132,08987762

Überblick

L-ornithine is an optically active form of ornithine having L-configuration. It has a role as a hepatoprotective agent, a mouse metabolite and an algal metabolite. It is an ornithine and a non-proteinogenic L-alpha-amino acid. It is a conjugate base of a L-ornithinium(1+). It is a conjugate acid of a L-ornithinate. It is an enantiomer of a D-ornithine.

Namen und Bezeichner

Bevorzugter Name
L-(-)-Ornithine
IUPAC
(2S)-2,5-diaminopentanoic acid
Englischer Name
polyornithine
Summenformel
C5H12N2O2
Molmasse
132.16098

Namen und Synonyme

L-ornithineornithine70-26-8(S)-2,5-Diaminopentanoic acid(S)-Ornithine(S)-2,5-diaminovaleric acid(2S)-2,5-diaminopentanoic acid(S)-alpha,delta-Diaminovaleric acidOrnitina(+)-S-OrnithineOrnithinum(S)-2,5-Diaminopentanoate
Weitere Namen anzeigen
polyornithineL-Ornithine, homopolymer
L-(-)-OrnithineNSC-758894E524N2IXA3CHEBI:15729DTXSID00883219CHEBI:18257DTXSID00860383RefChem:856923

Datenbank-Bezeichner

CAS
25104-12-5、3184-13-2、70-26-8
PubChem CID
6262
DTXSID
DTXSID00883219
ChEMBL
CHEMBL446143
ChEBI
CHEBI:15729
UNII
E524N2IXA3
EC Number
200-731-7
Nikkaji
J9.177D

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-4,4
Polarare Oberfläche (TPSA)
89,3 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
4
Schwere Atome
9

Experimentelle und physikochemische Eigenschaften

Chemical ClassesBiological Agents -> Amino Acids and Derivatives
DrugsPharmaceuticals -> Listed in ZINC15
CosmeticsSkin conditioning
SpringerMaterials Properties15N nuclear magnetic resonance spectrum
LogP-4.22
Solubility · 2 Einträge

Appreciable

620 mg/mL

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 3 Einträge

This chemical does not meet GHS hazard criteria for 100% (6 of 6) of all reports.

Not Classified

Aggregated GHS information provided per 6 reports by companies from 2 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: L-Ornithine

Status: Active Update: 13-04-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/23820

L-Ornithine: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - L-Ornithine: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

Toxikologische Informationen

Health Effects · 1 Eintrag

Chronically high levels of ornithine are associated with at least 9 inborn errors of metabolism including: Cystathionine Beta-Synthase Deficiency, Hyperornithinemia with gyrate atrophy, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperprolinemia Type II, Lysinuric Protein Intolerance, Ornithine Aminotransferase Deficiency, Ornithine Transcarbamylase Deficiency and Prolinemia Type II.

Exposure RoutesAbsorbed from the small intestine via a sodium-dependent active transport process
Toxicity Summary · 1 Eintrag

L-Ornithine is metabolised to L-arginine. L-arginine stimulates the pituitary release of growth hormone. Burns or other injuries affect the state of L-arginine in tissues throughout the body. As De novo synthesis of L-arginine during these conditions is usually not sufficient for normal immune function, nor for normal protein synthesis, L-ornithine may have immunomodulatory and wound-healing activities under these conditions (by virtue of its metabolism to L-arginine).

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataOral, rat LD<sub>50</sub> = 10000 mg/kg

Chemie und Industrie

Pharmakologische Informationen

Pharmacodynamics · 1 Eintrag

A non-essential and nonprotein amino acid, ornithine is critical for the production of the body's proteins, enzymes and muscle tissue. Ornithine plays a central role in the urea cycle and is important for the disposal of excess nitrogen (ammonia). Ornithine is the starting point for the synthesis of many polyamines such as putrescine and spermine. Ornithine supplements are claimed to enhance the release of growth hormone and to burn excess body fat. Ornithine is necessary for proper immune function and good liver function.

Mechanism of Action · 1 Eintrag

L-Ornithine is metabolised to L-arginine. L-arginine stimulates the pituitary release of growth hormone. Burns or other injuries affect the state of L-arginine in tissues throughout the body. As De novo synthesis of L-arginine during these conditions is usually not sufficient for normal immune function, nor for normal protein synthesis, L-ornithine may have immunomodulatory and wound-healing activities under these conditions (by virtue of its metabolism to L-arginine).

Metabolism/Metabolites · 2 Einträge

Ornithine undergoes extensive metabolism in the liver to L-arginine, polyamines, and proline, and several other metabolites.

Ornithine undergoes extensive metabolism in the liver to L-arginine, polyamines, and proline, and several other metabolites.

Absorption, Distribution and ExcretionAbsorbed from the small intestine via a sodium-dependent active transport process
Tissue LocationsEpidermis
Cellular LocationsExtracellular

Verwendung und Herstellung

Uses · 3 Einträge

A non-essential amino acid; Has been used in the treatment of hyperammonemia; [Merck Index]

Use (kg; approx.) in Germany (2009): >25000

Used for nutritional supplementation, also for treating dietary shortage or imbalance. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing.

Use ClassificationCosmetics -> Skin conditioning
General Manufacturing InformationL-Ornithine: ACTIVE

Anbieter2 Anbieter

Zugehörige Reaktionen

51

Verknüpfte Notizen

Wird geladen…